A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 17 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

News

News

All the latest news about the Access to Medicine Foundation, our research programmes and engagement activities. 

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

31 Jan 2020

Calls for action intensify at WEF launch for 2020 AMR Benchmark

New pledges to curb AMR followed the launch of the new Antimicrobial Resistance Benchmark during a high-level panel discussion at the 2020 WEF Annual...

21 Jan 2020

Signs of progress against the superbugs, but not yet at the scale needed

The 2020 Antimicrobial Resistance Benchmark evaluates how 30 pharmaceutical companies are limiting drug-resistance. Amsterdam, the Netherlands, 21 Ja...

20 Jan 2020

Next Access to Medicine Index to tighten focus on top access priorities for pharma

In the coming weeks, the Access to Medicine Foundation will publish its latest framework of action for pharmaceutical companies on access to medicine....

09 Jan 2020

2020 Antimicrobial Resistance Benchmark launches on 21 January

The 2nd AMR Benchmark report will go live on Tuesday 21 January. It will give a reality check on how the biggest players in anti-infectives markets ar...

19 Nov 2019

Out in Jan: 2nd Benchmark of pharma companies' actions on antibiotic resistance and access

The 2020 Antimicrobial Resistance Benchmark will be published in January next year. In this new report, the Access to Medicine Foundation will address...

29 Aug 2019

Foundation names Expert Review Committee for next Access to Medicine Index

The Foundation is pleased to announce the members of the Expert Review Committee for the next Access to Medicine Index, including six new members in 2...

22 Jul 2019

Pharma companies in Amsterdam for Foundation workshop on achieving access to medicine at scale

In its latest workshop, the Access to Medicine Foundation brought strategic leads from within pharmaceutical companies together with independent exper...

16 May 2019

New study from the Foundation analyses 10 years of data on pharma companies and access to medicine

Amsterdam, the Netherlands, 16 May 2019 – In a new report published today, the Access to Medicine Foundation shows where pharmaceutical companies have...

19 Apr 2019

UBS Asset Management: 90th investor to endorse the Access to Medicine Index

Eight new investors have pledged support to the Foundation’s research and signed the Access to Medicine Index Investor Statement since the release of...

06 Mar 2019

In tribute to Dilip Shah

We were deeply saddened to learn that Dilip Shah passed away on 22 February 2019. Dilip was one of the Foundation’s earliest supporters, advising as p...

14 Feb 2019

Toward the next AMR Benchmark: new methodology now online

The world needs new antibiotics and smarter ways of using existing ones if the benefits of life-saving treatments first discovered nearly a century ag...

29 Nov 2018

2018 Access to Medicine Index finds that pharmaceutical companies are deepening their focus on Africa

Amsterdam, the Netherlands, 29 November 2018 – The new Access to Medicine Index notes increasing interest from multinational pharmaceutical companies...

20 Nov 2018

Now online: 6th Access to Medicine Index

The 2018 Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the po...

20 Nov 2018

Coming up: Index briefings to inform policy on global health

The Access to Medicine Foundation will be holding a series of policy and technical briefings with government representatives from Germany, Japan...

20 Nov 2018

New online: you choose which companies to compare side by side

We are publishing the new Access to Medicine Index on a new website. Our goal was to make it easier for you to find what you are looking for and to co...

05 Nov 2018

Goldman Sachs & UBS to co-host investor launches of 2018 Access to Medicine Index

On Thursday 22 November, Goldman Sachs will co-host the London investor event about the 2018 Index together with the Access to Medicine Foundation. Tw...

Back to top |